Our goal: We will be a convenor, collaborator and partner of choice to facilitate the flow of ideas, talent and innovation to tackle grand global challenges.

Now: We are proud to be one of the world's most international universities. Our global collaborations, discoveries and networks are transforming lives and creating opportunity in the UK and around the world. Our global community brings people together to contribute diverse perspectives, new ideas and fresh approaches to solving complex problems. Our global network of alumni, friends and collaborators amplify our reach and impact.

International collaboration is in Imperial’s DNA and at the core of our research: our academics have forged research collaborations in over 190 countries. We enjoy strong bilateral research partnerships with universities and institutes including Technical University of Munich, Nanyang Technological University, Massachusetts Institute of Technology, African Institute for Mathematical Sciences, Indian Institute of Science Bangalore, Tsinghua University and Centre National de la Recherche Scientifique.

Next: Imperial Global will bring even more of our work to the world, and more of the world to our work, amplifying our impact through a network of hubs in strategic global cities. This network will demonstrate our commitment to building long-term collaborations with a diverse range of partners and stakeholders, foster new high-impact partnerships with industry, government and knowledge organisations, and give us the opportunity to develop deeper links with our alumni.

Our first hubs will be in Singapore, Ghana, the USA and India. They will share characteristics that draw on Imperial’s unique strengths but have different activity profiles that build on existing partnerships and local needs and opportunities.

Imperial Global Singapore is a new presence on Singapore’s CREATE campus initially exploring the cyber security of medical devices. It will allow us to develop significant new research and translation programmes with partners across South East Asia, and support recruitment and career development activities.

Imperial Global Ghana builds on established partnerships in medical diagnostics, sustainable cities and entrepreneurship training. It will be a knowledge hub that develops major programmes across West Africa to increase the number, quality and impact of equitable STEMB partnerships with African stakeholders. It underlines our commitment to building long-term, equitable partnerships on the Continent.

Imperial Global USA will strengthen our research partnerships with US academic and industrial partners and support our growing US alumni network and student recruitment opportunities.

Imperial Global India will build Imperial’s profile and partnerships in an emerging scientific and industrial superpower. The hub will strengthen the important UK-India knowledge bridge to enable STEMB talent to drive forward research, education and innovation in key areas including clean technology, fintech and biosciences.

Imperial Global will enhance our academic partnerships, access to talent, enterprise and engagement. Most importantly, it will become a core part of our efforts to apply science for the good of humanity.

“There is a critical need for local capacity to rapidly respond to known and unknown threats in key areas like infectious disease. The Imperial Global network will bring us closer to the people, partners and potential solutions. This includes the critical area of vaccine access where a Ghana centre can support our major Africa-led Chanjo Hub to accelerate global access to vaccinations and treatments.” - Professor Faith Osier, Chair, Immunology & Vaccinology

Equitable Vaccine Access and Development

Nearly one in five infants across the world does not have access to vaccines, and almost one third of deaths among children under five could be prevented through the use of vaccines. Imperial is leading two major vaccine manufacturing hubs to develop new technologies that can be quickly, easily and affordably manufactured in the places most vulnerable to infectious disease.

The Chanjo Hub is an African-led collaboration designed to catalyze local research and innovation ecosystems in Kenya and Ghana in order to deliver vaccines for endemic and epidemic diseases in the region. The Future Vaccine Manufacturing Research Hub is focused on disruptive technology that allows developing countries to produce tailored vaccines within 100 days of an identified outbreak or threat. Novel manufacturing programmes are currently being developed with partners in Vietnam, Bangladesh and South Africa.